Box score
Ansa Biotechnologies, Inc.
Reported $54.4M sold in a new Form D filed November 18, 2026 (Emeryville, California).
- Biggest raise
- $54.4M filed Nov 18, 2026
- League
- Bio & Health Biotechnology
- Based in
- Emeryville, California
- Season rank
- #52 of 1,212 in the Bio & Health League; #484 of 11,716 overall (2026)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-11-18 | New notice | $54.4M | $71.9M | SEC |
| 2025-12-10 | Amendment | $46.4M | $56.9M | SEC |
| 2025-10-02 | New notice not ranked | $45.2M | $55.5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1816722.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Iambic Therapeutics, Inc. | Bio & Health | $66M |
| 2 | AirNexis Therapeutics, Inc. rookie | Bio & Health | $62M |
| 3 | Moonwalk Biosciences, Inc. | Bio & Health | $60M |
| 4 | Claris Biotherapeutics, Inc. | Bio & Health | $55.7M |
| 5 | Caspian Therapeutics, Inc. rookie | Bio & Health | $50M |
| 6 | Jaguar Health, Inc. provisional | Bio & Health | $40.8M |